RAF kinase functions in the mitogen-activated protein kinase (MAPK) pathway to transmit growth signals to the downstream kinases MEK and ERK. Activation of RAF catalytic activity is facilitated by a regulatory complex comprising the proteins CNK (Connector enhancer of KSR), HYP (Hyphen), and KSR (Kinase Suppressor of Ras). The sterile ␣-motif (SAM) domain found in both CNK and HYP plays an essential role in complex formation. Here, we have determined the x-ray crystal structure of the SAM domain of CNK in complex with the SAM domain of HYP. The structure reveals a single-junction SAM domain dimer of 1:1 stoichiometry in which the binding mode is a variation of polymeric SAM domain interactions. Through in vitro and in vivo mutational analyses, we show that the specific mode of dimerization revealed by the crystal structure is essential for RAF signaling and facilitates the recruitment of KSR to form the CNK/HYP/KSR regulatory complex. We present two docking-site models to account for how SAM domain dimerization might influence the formation of a higher-order CNK/HYP/KSR complex. RAF kinases are downstream effectors of the RAS family of small GTPases (reviewed in ref. 4). Although the events leading to RAS activation are now well understood, the precise mechanism by which activated RAS in turn activates RAF to transduce signals to MEK and ERK remains unclear (5). Studies in Drosophila S2 cells revealed that activation of RAF kinase at sites of RAS-mediated signaling is facilitated by a regulatory complex comprising the proteins CNK (Connector enhancer of KSR), HYP (Hyphen, also known as Aveugle or AVE), and KSR (Kinase Suppressor of RAS) (6, 7). The sterile ␣-motif (SAM) domain, present in both CNK and HYP, is essential for the ability of CNK/HYP/KSR to associate and for signals to transduce through the RAF-MEK-ERK cascade (6); see Fig. 1A for schematic of domain architecture.
mation of a large signaling complex that recruits an activator of RAF (7) .
In this report, we show that the CNK/HYP interaction is in fact mediated directly by their SAM domains. However, by using x-ray crystallography, we demonstrate that the SAM domain of CNK forms a finite (discrete) heterodimer with the SAM domain of HYP. This interaction occurs through a ML/EH binding mode that is very similar to that seen in polymeric SAM interactions. A 1:1 binding stoichiometry results from the presence of only a single interaction surface on the CNK and HYP SAM domains. We show that SAM domain-mediated dimerization of CNK/HYP is essential for RAF signaling in vivo. Furthermore, we show that CNK/HYP dimerization is necessary to recruit KSR to form a CNK/HYP/KSR complex through a direct interaction with the kinase domain of KSR. This suggests that, in addition to merely acting as a passive protein-protein interaction module, SAM domains can also function as molecular switches to regulate further signaling events. The CNK/HYP SAM domain complex structure adds to the versatility in binding modes exemplified by this abundant protein domain.
Results
The SAM Domains of CNK and HYP Form a Stable Complex. To determine whether the SAM domains of CNK and HYP interact directly and independently of other factors, we expressed minimal SAM domain constructs in bacteria and tested for an interaction by using an in vitro pull-down assay. We screened for suitable expression constructs for the SAM domains of CNK and HYP from different species including Drosophila, mouse, and human. We successfully identified expression constructs for the SAM domains of human CNK2 (hCNK2 SAM ) and Drosophila HYP (dHYP SAM ). By using a GST pull-down assay, we found that GST-dHYP SAM bound to hCNK2 SAM (Fig. 1B) . In contrast, GST protein alone or the RNA binding SAM domain of Vts1 fused to GST did not bind to hCNK2 SAM . Because SAM domain interactions are known to form multiple oligomeric states, we performed size exclusion chromatography experiments to estimate the stoichiometry of the overall hCNK2 SAM /dHYP SAM complex. Separately, purified hCNK2 SAM and dHYP SAM elute as monomers, whereas a copurified hCNK2 SAM /dHYP SAM complex elutes with an apparent molecular mass consistent with a dimeric complex [see supporting information (SI) Fig. 5 ]. To determine the dissociation constant for dimerization, we used surface plasmon resonance experiments and found that the K d for dimerization is 92.5 nM (SI Fig. 6 ). Taken together, these results indicate that hCNK2 SAM binds tightly and directly in vitro with an apparent 1:1 stoichiometry to the dHYP SAM domain.
Structure of the hCNK2 SAM /dHYP SAM Complex. Because the ML/EH binding mode is characteristic of polymeric SAM domains, we questioned whether the discrete dimerization of hCNK2 SAM / dHYP SAM involves a novel binding mode or a variation of the polymerization binding mode. To distinguish between these two possibilities, we solved the structure of the hCNK2 SAM / dHYP SAM complex by x-ray crystallography. Crystals containing a single copy of the complex in the asymmetric unit, belonging to the space group P2 1 2 1 2 1 , were obtained and the structure was solved by using the selenomethionine single-wavelength anomalous dispersion (SAD) phasing method. The final model was refined to 2.0-Å resolution to an R factor /R free of 21.4%/24.0%. We also obtained crystals of the isolated dHYP SAM containing two monomers in the asymmetric unit belonging to the space group C222 1 . The isolated dHYP SAM structure was solved by molecular replacement by using the dHYP SA M structure from the hCNK2 SAM /dHYP SAM complex as a search model. The final isolated dHYP SAM structure was refined at 1.9-Å resolution to an R factor /R free of 21.7%/26.5%. Pertinent structure determination and refinement statistics are presented in SI Table 1 .
Both hCNK2 SAM and dHYP SAM adopt the canonical five helix (␣1-␣5) SAM domain fold in complex ( Fig. 2A) . The structure of dHYP SAM bound to hCNK2 SAM is virtually unchanged from the isolated dHYP SAM structure with a rms deviation of 0.4 Å for 74 C␣ atoms (SI Fig. 7 ). The structure of the complex reveals heterodimerization to be a variation of the polymer theme in which the EH surface of hCNK2 SAM engages the ML surface of dHYP SAM (Fig.  2B) . The hCNK2 SAM /dHYP SAM interface buries Ϸ580 Å 2 of surface area on each SAM domain and involves a higher proportion of polar contacts than observed previously in other ML/EH SAM domain complexes (8) (9) (10) (11) (12) (13) (14) . The ML surface of dHYP SAM is partly comprised by Asp-53, Arg-57, Arg-61, and Arg-69. These charged residues engage in multiple salt-bridge interactions with the oppositely charged side chains of Asp-24, Glu-53, His-62, Glu-64, Glu-68, and Asp-71 on the EH surface of hCNK2 SAM (Fig. 2B) . Hydrophobic dimer contacts are formed by Ile-54, Ala-58, and Ile-62 on the ML surface of dHYP SAM and by Ile-60, Gly-61, and Leu-65 on the EH surface of hCNK2 SAM . The small side chain of Gly-61 allows hCNK2 SAM helix ␣5 to pack tightly against the ML surface of dHYP SAM .
Consistent with the finding that the hCNK2 SAM /dHYP SAM complex is a discrete dimer and not a polymer, only one of the two polymerizing surfaces on each SAM domain is highly conserved. Specifically, the EH surface on hCNK2 SAM orthologues and the ML surface on dHYP SAM orthologues show striking conservation (Fig.  3) . Notably, the ML surface of hCNK2 SAM and the EH surface of dHYP SAM are not conserved in orthologous proteins. This contrasts sharply with the polymerizing SAM domain of Polyhomeotic (Ph SAM ) for which both the ML and EH surfaces are conserved (Fig. 3) . The inability of hCNK2 SAM and dHYP SAM to interact by their ML and EH surfaces, respectively, would explain why the two proteins form discrete dimers rather than extended polymers.
Validation of the hCNK2 SAM /dHYP SAM Dimer Interface: In Vitro. To identify the essential determinants of dimerization and to confirm that the crystal structure reflects the solution structure of the hCNK2 SAM /dHYP SAM complex, we individually substituted surface contact residues on hCNK2 SAM and dHYP SAM and analyzed the interaction potential of these mutants by using a GST pull-down assay (Fig. 4 A and B) . In agreement with predictions from the crystal structure, a R61E charge reversal mutation on the ML surface of dHYP SAM strongly reduced binding to hCNK2 SAM (Fig.  4A ). Introduction of a double-charge reversal R57E/R61E at the ML surface resulted in no detectable interaction with hCNK2 SAM . In contrast, a R57A/R61A double mutant showed only a reduced ability to interact.
In converse experiments, a R59S/E68G double mutation or the D71A single mutation on the EH surface of hCNK2 SAM had no effect on the capacity to interact with GST-dHYP SAM (Fig. 4B) . The D71R and I60A single mutants of the EH surface showed a modestly reduced ability to bind GST-dHYP SAM . The doublecharge reversal E68R/D71R at the EH surface resulted in no detectable interaction with GST-dHYP SAM . A control mutation Y78A outside the EH surface on hCNK2 SAM had no effect on binding to GST-dHYP SAM . These results confirm that the x-ray structure reflects the solution interaction of hCNK2 SAM /dHYP SAM . The observation that different mutants had different effects on the ability to dimerize can be reconciled by the crystal structure. The R57E/R61E dHYP SAM double mutant likely destabilizes the SAM/SAM complex most by abrogating four favorable salt-bridge interactions and introducing a strong electrostatic repulsion at the interface (Fig. 2B ). The single R61E dHYP SAM mutant perturbs only two salt-bridge interactions and introduces a weaker electrostatic repulsion than with the R57E/R61E dHYP SAM mutant, thus disrupting the interaction to a lesser extent (Fig. 4A) . The R57A/ R61A dHYP SAM mutant perturbs four salt-bridge interactions, but does not introduce any electrostatic repulsion at the interface. Hence, the R57A/R61A mutant shows the least effect on perturbing dimerization relative to the charge reversal mutations. A similar rationale explains the more potent effect on dimerization caused by the D71R charge reversal mutant of hCNK2 SAM versus the D71A mutant (Fig. 4B) .
Validation of the hCNK2 SAM /dHYP SAM Dimer Interface: In Vivo. We next sought verification that the cross-species complex between hCNK2 SAM and dHYP SAM in the crystal structure and in solution reflects the homo-species complex formed by dCNK/dHYP in vivo. For this, we prepared a series of mutants that targeted SAM domain dimer interface surface residues on dHYP and dCNK constructs. For dCNK, we used a construct that included the SAM-CRIC-PDZ regions (denoted dCNK 2-549 ; see Fig. 1 A), because the SAM domain alone or a SAM-CRIC construct were not detectably expressed in S2 cells. We then introduced mutations of interface residues equivalent to those on the EH surface of hCNK2 SAM in dCNK . The mutant constructs were transfected into S2 cells and the overexpressed proteins were tested for binding in a GST pull-down assay (Fig. 4C) . Although wild-type dHYP bound strongly to wild-type dCNK , the single mutation R61D and the double mutation R57A/R61A on dHYP severely reduced binding to wild type dCNK (Fig. 4C) . The double-charge reversal mutation R57D/R61D on dHYP caused the strongest reduction on the interaction with dCNK 2-549 , consistent with the strongest effect seen for the double-charge reversal in the in vitro pull-down assay (Fig. 4A) .
On the EH surface of dCNK 2-549 , the double mutation R57S/ E66G and the single mutation E69A each showed a minor effect on the ability to interact with dHYP (Fig. 4D) . The single mutations E69R and I58A each showed a moderately reduced capacity to interact with dHYP, whereas the double-charge reversal E66R/ E69R on the EH surface of dCNK showed a complete loss of binding, paralleling the effects seen in vitro. The control mutation Y76A on dCNK 2-549 on a surface outside the dimer interface had no effect on binding. These results confirm that the dimer interface revealed by the crystal structure of hCNK2 SAM /dHYP SAM reflects the interaction of dCNK 2-549 /dHYP in vivo.
CNK/HYP Dimerization Is Essential for RAF Signaling in Vivo.
We next tested the relevance of the CNK/HYP SAM domain interaction for RAF activation downstream of a dominant active mutant of RAS (Ras V12 ) in S2 cells. In this assay, the co-overexpression of Ras V12 , RAF, KSR, and MEK is sufficient to reconstitute RAF signaling in a dCNK 2-549 -and dHYP-dependent manner. Activation of RAF kinase results in phosphorylation of its substrate MEK that can be detected by immunoblotting with an anti-phospho-MEK antibody. Using RNAi, we depleted endogenous dHYP and found that this abolishes MEK phosphorylation as reported (6) (Fig. 4E; SI Fig. 8 ).
We then introduced RNAi-insensitive variants of wild-type or dimerization-defective dHYP constructs and tested for their ability to restore RAF kinase activity as indicated by phospho-MEK levels. Although wild-type dHYP restored MEK phosphorylation, the R57D/R61D dHYP mutant failed to restore phospho-MEK levels, indicating that a direct dCNK SAM /dHYP SAM interaction is essential for RAF signaling. Surprisingly, the R61D and R57A/R61A dHYP mutants fully restore phospho-MEK levels to that of wild-type dHYP, despite their reduced binding to dCNK in the previous pull-down assay (Fig. 4C) . These results indicate that, although the R61D and R57A/R61A dHYP mutants are both impaired in their capacity to bind dCNK , only the stronger R57D/R61D dHYP mutant shows both impaired binding and RAF-signaling defects.
A CNK/HYP Complex Recruits KSR. The reduced interaction of the R61D and R57A/R61A dHYP mutants with dCNK 2-549 contrasts with the apparently normal function of these mutants in RAF signaling in vivo. We reasoned that this apparent contradiction could be attributed to CNK and HYP acting within a larger protein complex. In this context, secondary interactions outside of the SAM domain are sufficient to stabilize protein complex formation in the case of weakly perturbing SAM/SAM mutations. One simple explanation then for the outwardly normal restoration of phospho-MEK levels in our RAF-signaling assay by R61D and R57A/R61A dHYP mutants is that the co-overexpression of other signaling components in the assay, such as Ras V12 , RAF, KSR, and MEK, offsets the weaker dimerization defect of R61D and R57A/R61A dHYP mutants.
To characterize the component(s) that may be compensating for the R61D and R57A/R61A dHYP mutations, we first determined whether the co-overexpression of Ras V12 , RAF, GST pull-down assay from S2 cell co-overexpressing wild-type or dimer interface mutants of GST-dHYP or dCNK . The Y76A substitution served as a control. Equal expression of GST-dHYP and dCNK 2-549 proteins were confirmed by ␣GST and ␣CNK blotting of the primary lysates, respectively. (E) dHYP dimer interface mutants were tested for their ability to stimulate RAF activity as measured by MEK phosphorylation (pMEK) levels. (F) GST pull-down assays were performed as in Fig. 4C , except S2 cells were cotransfected with wild-type dCNK 2-549 , wild-type, or indicated GST-dHYP mutants, Ras V12 , RAF, KSR, and MEK. (G) Similar GST-pull downs as in Fig. 4F were repeated in the presence of wild-type dCNK 2-549 , KSR kinase domain and MEK along with wild type or the indicated GST-dHYP mutants. Equal expression of proteins was confirmed by blotting of the primary lysates.
KSR, and MEK as in our RAF-signaling assay could restore the binding of R61D and R57A/R61A dHYP mutants to dCNK in the GST pull-down assay. As shown in Fig. 4F , this is indeed what we observed because the R61D and R57A/R61A dHYP mutants associate with dCNK 2-549 as efficiently as wild-type dHYP when co-overexpressed with Ras V12 , RAF, KSR, and MEK. In contrast, the R57D/R61D dHYP mutant is still defective in binding to dCNK . Next, we attempted to identify which of Ras V12 , RAF, KSR, and MEK contribute to the restored binding of R61D and R57A/R61A dHYP mutants to dCNK . Because the function of CNK in promoting RAF activation was previously shown to depend on determinants within the kinase domain of KSR (6), we hypothesized that the kinase domain of KSR might compensate for the dimerization defect of R61D and R57A/R61A dHYP mutants. To test this, we co-overexpressed KSR kinase domain along with dHYP and dCNK to test for binding in our GST pull-down assay (MEK was also coexpressed with KSR kinase domain because overexpressed KSR kinase domain alone is unstable in the absence of co-overexpressed MEK). As shown in Fig. 4G , under these conditions, the R61D and R57A/R61A dHYP mutants associate with dCNK 2-549 as stably as wild-type dHYP, even though these mutants showed a significantly reduced binding to dCNK in the absence of co-overexpressed KSR kinase domain (Fig. 4C) . In contrast, the R57D/R61D dHYP mutant is still severely impaired in binding to dCNK . These results are consistent with our RAF-signaling results and identify KSR as part of the dCNK 2-549 / dHYP complex that stabilizes the SAM-SAM interaction. Moreover, the pull-down assays localize the minimal region of KSR required for this effect to be the protein kinase domain (Fig. 4G) . Taken together, our results suggest that the dimerization of CNK and HYP mediated by their SAM domains facilitates KSR recruitment through the kinase domain of KSR to form the CNK/HYP/ KSR complex.
Models for KSR Binding to CNK/HYP. The compromised interaction of the kinase domain of KSR in the context of the R57D/R61D dHYP mutant suggests that the SAM/SAM complex of CNK/HYP might form a composite docking site for KSR binding. We reasoned that if such a site existed, we might be able to identify it on the basis of sequence conservation as seen for the ML/EH surfaces. By mapping conserved surface residues on the hCNK2 SAM /dHYP SAM complex, we identified a candidate interaction site encompassing the C termini of helix ␣5 in both CNK and HYP SAM domains. This region of each SAM domain is solvent-exposed, reasonably well conserved, and spatially juxtaposed (SI Fig. 9A) . Consistent with the possibility that this region constitutes an interaction site for the kinase domain of KSR as modeled in SI Fig. 9B , we found that a triple mutation D81A/N82A/L83A in CNK targeting three conserved residues just outside the last ordered residue seen in our crystal structure selectively perturbs the interaction with KSR, but not with HYP (data not shown).
Our ability to test this composite binding site model was hampered by protein expression issues. Specifically, we cannot express the isolated SAM domains of dCNK or hHYP or the kinase domain of hKSR, which would allow us to test for direct binding of proteins from a common species. We found that a minimal SAM domain dimer between hCNK2 and dHYP does not bind to the kinase domain of dKSR, but that this was likely due to a cross-species effect (SI Fig. 10 A and B) . Indeed, whereas a single-species complex between dCNK 2-549 /dHYP binds to the kinase domain of dKSR, the equivalent cross-species complex of hCNK2 2-485 /dHYP does not (SI Fig. 10B ). As such, a second KSR binding model that cannot be ruled out at this time is one in which the CRIC-PDZ region C-terminal to the SAM domain in CNK constitutes the KSR kinase domain binding site. Presumably, this site remains hidden until the SAM domain of HYP engages the SAM domain of CNK (SI Fig. 9C ). Discussion CNK/HYP/KSR Complex Is Required for RAF Signaling. Building on previous biochemical studies, our results present a structural link between CNK, HYP, and KSR in RAS-induced RAF activation. We find that SAM domains mediate direct interaction between CNK and HYP. The CNK SAM /HYP SAM complex forms a discrete ML/EH surface dimer incapable of polymerization. We show that this dimerization event is required to recruit KSR to form a CNK/HYP/KSR regulatory complex necessary for signaling through the RAF-MEK-ERK module.
The formation of the CNK/HYP/KSR complex involves minimally the SAM domains of CNK/HYP and the kinase domain of KSR. It is worth noting that, although we coexpressed KSR with MEK in our in vivo assays and this raises the possibility that MEK bridges the CNK/HYP/KSR interaction, this scenario is unlikely. First, previous studies showed that endogenous CNK/HYP/KSR complex formation is unperturbed in the presence of RNAi knockdown of endogenous MEK in S2 cells, but complex formation is compromised by RNAi against endogenous CNK, HYP, or KSR (6). Second, KSR mutants unable to interact with MEK still retain their capacity to bind CNK/HYP (data not shown). Thus, we reason that in the context of our overexpressed pull-down assays, MEK serves only to improve expression of the kinase domain of KSR.
Structural Basis for Discrete SAM Domain Interactions. Our structural characterization of the hCNK2 SAM /dHYP SAM complex provides the first high-resolution view of a discrete SAM/SAM complex and reveals that discrete SAM domain dimerization can also occur through the ML and EH surfaces previously known to mediate polymerization. The ML surface on HYP SAM has evolved to selectively recognize the EH surface on CNK SAM with high affinity. In contrast, the EH and ML surfaces on HYP SAM and CNK SAM , respectively, are nonfunctional and show no sequence conservation across species. We presume that there has been no selective pressure for maintaining residues at the nonfunctional surfaces.
We reason that discrete dimerization of SAM domains, as seen for the hCNK2 SAM /dHYP SAM interaction, might have relevance for other SAM domain interactions in addition to the more common polymeric interactions that have been reported (8) (9) (10) (11) (12) (13) (14) . Indeed, a recent study has identified the SAM domain complex of Arap3/ SHIP2 that forms discrete dimers in solution (20) . Whether the Arap3/SHIP2 mode of dimerization also involves ML/EH surfaces is unknown. Regardless, the involvement of the ML/EH surfaces in other discrete SAM domain interactions is also suggested from a mutational analysis on the SAM domain interaction of Byr2 and Ste4 in which residues at the putative ML and EH surfaces, respectively, were found to contribute to the formation of finite oligomers (21) .
Conclusion
The dysregulation of RAF and its upstream regulator RAS in many human tumors and the drugability of protein kinases in general has identified RAF as an attractive target for therapeutic intervention (22) . Because RAF activation depends on the action of the CNK/ HYP/KSR complex, this complex too might provide targets for intervention in this regard. Our work identifies specific interactions that are essential for RAF activity and may in the future be amenable to modulation by small molecule inhibitors.
Materials and Methods
Plasmids. The SAM domain of human CNK2 (residues 5-84) was amplified by PCR and subcloned into the pProEx-HTa expression vector (Invitrogen). Full-length dHYP and the minimal SAM domain construct (residues 21-98) were PCRamplified and inserted into the pETM-30 vector (EMBL, Protein Expression Facility). Variant SAM domain mutants were generated by two-step PCR-based targeted mutagenesis.
Copper-inducible pMet vectors were used for binding and functional assays conducted in S2 cells (23) . pMet-HA-RAS V12 , pMet-MYC-MEK, pMet-PYO-RAF, pMet-V5-KSR, pMet-PYO-HYP, HYP dsRNAs, and pMet-FLAG-dCNK 2-549 have been described (6, 24) . pMet-GST-HYP was generated in two steps. First, a GST cDNA (pGEX4T; Amersham Biosciences) containing a 6xHis tag and a TEV cleavage site at its C terminus was amplified by PCR and introduced in pMet vector. Second, a Drosophila Hyphen cDNA (residues 2-106) was amplified by PCR and introduced at the C terminus of GST-His-TEV to create pMet-GST-HYP. Variant HYP and CNK mutants were generated by using the QuikChange procedure (Clontech).
Protein Expression and Purification. Proteins were expressed in Escherichia coli BL21 (DE3) strain (Novagen). Proteins were purified by Ni affinity chromatography by using a HiTrap Chelating HP column (Amersham) and eluted with imidazole. The eluate was treated with TEV to cleave off the 6xHis tag in pProEx-HTa or the 6xHis-GST tag in pETM-30. TEV-cleaved proteins were dialyzed into buffer and applied to a HiTrap Chelating HP column to elute untagged proteins. Eluate was concentrated and applied to a Superdex 75 gel filtration column (Amersham) for final purification. To obtain a selenomethionyl derivative of hCNK2 SAM and dHYP SAM , E. coli B834 cells were transformed and grown in minimal medium supplemented with selenomethionine. All proteins were purified into buffer containing 10 mM Hepes (pH 7.0), 200 mM NaCl, and 5 mM ␤-mercaptoethanol.
Crystallization, Data Collection, Structure Determination, and Modeling. Crystals were grown by the hanging-drop vapor diffusion method. hCNK2 SAM /dHYP SAM cocrystals were grown at 4°C by mixing 1 l of 4-8 mg⅐ml Ϫ1 of each protein with 1 l of well buffer (100 mM Tris, pH 7.0 -7.5, and 12-18% PEG 2000 MME). Flash-freezing of the crystals was performed by using the crystallization buffer supplemented with 25% (vol/vol) glycerol. Data were collected at the Advanced Photon Source (APS) of the Argonne National Laboratory on Beamline 24-ID of NE-CAT and analyzed by using the HKL2000 software package (25) . The SHELX (26) set of programs was used to locate heavy-atom sites, calculate phases, and perform density modification. Electron density maps calculated from the phases after density modification were used to build an initial model in ARP/wARP (27) and refined by using REFMAC5 (28) in the CCP4 software package. A representative ͉2Fo Ϫ Fc͉ map of the hCNK2 SAM /dHYP SAM complex is shown in SI Fig. 11 . dHYP SAM alone crystals were grown at 20°C by mixing 1 l of 13 mg⅐ml Ϫ1 protein with 1 l of well buffer (100 mM cacodylate, pH 6.5, and 1 M sodium citrate). Flash-freezing of the crystals was performed by using the crystallization buffer supplemented with 25% (vol/vol) glycerol. Data were collected under a liquid nitrogen stream at the APS on Beamline 14-BM-C of BioCARS and analyzed by using the HKL2000 software package (25) . The program PHASER (29) in the CCP4 package was used to find a molecular replacement solution based on the dHYP SAM structure of the hCNK2 SAM /dHYP SAM complex as the search model. REFMAC5 (28) was used for iterative cycles of refinement in between manual refinement by using Coot (30) . Ribbons and surface representations were generated by using PyMOL (DeLano Scientific).
Surface Plasmon Resonance Experiments. Surface plasmon resonance experiments for the hCNK2 SAM /dHYP SAM interaction were performed at room temperature in 10 mM Hepes, pH 7.0, and 200 mM NaCl. dHYP SAM was immobilized on a Biacore Pioneer CM5 sensor chip (GE Healthcare) according to the manufacturer's instructions. Free hCNK2 SAM protein was injected and the binding data were analyzed by using BIAevaluation 3.0 software.
GST Pull-Down Assays. A 30-l sample of 50% slurry of glutathione Sepharose 4B beads (Amersham Pharmacia) was equilibrated in assay buffer (10 mM Hepes, pH 7.0, 100 mM NaCl, and 10 mM ␤-mercaptoethanol). The slurry was mixed with 30 l of Ϸ4 mg⅐ml Ϫ1 GST-fusion protein and incubated for 15 min at 4°C on a nutator. The beads were washed three times with 1 ml of the assay buffer and then nutated with 30 l of 4 mg⅐ml Ϫ1 of 6xHis-tagged protein in a final volume of a 500-l assay buffer for 1 h at 4°C. The beads were subjected to three washes with 1 ml of the assay buffer. SDS loading buffer was added to the samples and heated at 90°C for 10 min. Proteins were resolved on precast 4 -20% (Invitrogen) SDS/ PAGE and visualized by Coomassie blue staining. Identical samples were resolved by 17% SDS/PAGE and subjected to immunoblot analysis by using antibodies specific for the 6xHis tag (Sigma).
S2
Cell Assays. S2 cells were grown in serum-free insect cell medium (Sigma). Transfection and induction of protein expression were conducted as described in ref. 24 . At 36 h postinduction cells were lysed in Nonidet P-40 lysis buffer (20 mM Tris, pH 8.0, 137 mM NaCl, 1% Nonidet P-40, 10% glycerol, and 1 mM EDTA).
For GST pull-down assays, 50 l of 50% slurry of glutathione Sepharose 4B beads (GE Healthcare) equilibrated in lysis buffer was added to protein lysates and rocked for 4 h at 4°C. Beads were then washed three times with 1 ml of lysis buffer and proteins were eluted with 50 l of elution buffer (5 mM L-glutathione, 50 mM Tris, pH 8.0).
Total protein lysates or eluted proteins were resolved on 8 -10% SDS/PAGE, transferred to nitrocellulose membranes and immuno-detected by using either rabbit ␣-GST (Calbiochem), mouse ␣-V5 (Invitrogen), rabbit ␣-pMEK (Cell Signaling), or mouse antibodies ␣-CNK, ␣-MYC, ␣-PYO, and ␣-HA as described in ref. 31 .
